WaterlowJC. Nutritional liver disease in West Indian infants. Proc Roy Soc Med. 1947;40(7):347-350.
2.
WaterlowJC. Fatty livers in the West Indies. Lancet. 1948;251(6507):769-660.
3.
OgdenCLCarrollMDKitBKFlegalKM. Prevalence of Obesity in the United States, 2009-2010. Hyattsville, MD: National Center for Health Statistics; 2012. NCHS Data Brief No. 82.
4.
RahimiRSLandaverdeC. Nonalcoholic fatty liver disease and the metabolic syndrome: clinical implications and treatment. Nutr Clin Pract. 2013;28(1):40-51.
5.
YounossiZMStepanovaMAfendyM. Changes in the prevalence of the most common causes of chronic liver diseases in the United States from 1988 to 2008. Clin Gastroenterol Hepatol. 2011;9(6):524-530.
6.
JohnsonTMOvergardEBCohenAEDiBaiseJK. Nutrition assessment and management in advanced liver disease. Nutr Clin Pract. 2013;28(1):15-29.
7.
ButterworthRF. Metal toxicity, liver disease and neurodegeneration. Neurotox Res. 2010;18(1):100-105.
8.
TillmanEM. Review and clinical update on parenteral nutrition–associated liver disease. Nutr Clin Pract. 2013;28(1):30-39.
9.
BlackmerABBaileyE. Management of copper deficiency in cholestatic infants: review of the literature and a case series. Nutr Clin Pract. 2013;28(1):75-86.
10.
McCarthyEMRinellaME. The role of diet and nutrient composition in nonalcoholic fatty liver disease. J Acad Nutr Diet. 2012;112(3):401-409.
11.
MouzakiMAllardJP. The role of nutrients in the development, progression, and treatment of nonalcoholic fatty liver disease. J Clin Gastroenterol. 2012;46(6):457-467.
12.
PlankLDGaneEJPengS. Nocturnal nutritional supplementation improves total body protein status of patients with liver cirrhosis: a randomized 12-month trial. Hepatology. 2008;48(2):557-566.
13.
MullinG. The use of complementary and alternative medicine for liver disease: part I. Nutr Clin Pract. 2013;28(1):138-139.
14.
YadavACareyEJ. Osteoporosis in chronic liver disease. Nutr Clin Pract. 2013;28(1):52-64.